4.7 Article

Long-term outcomes in young patients with atrioventricular block of unknown aetiology

期刊

EUROPEAN HEART JOURNAL
卷 42, 期 21, 页码 2060-2068

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehab060

关键词

Atrioventricular block; Long-term outcomes; Young; Pacemaker implantation; Unknown aetiology; Follow-up

资金

  1. Skibsreder Per Henriksen, R. og hustrus Foundation
  2. Danish Heart Foundation [16-R107-A6707-22988]
  3. Novo Nordisk Foundation, Denmark [NNF18OC0031258]
  4. A. P. Moller Foundation for the Advancement of Medical Science

向作者/读者索取更多资源

Atrialventricular block of unknown etiology in young patients is rare, and this study aimed to assess the long-term outcomes in this group. The findings showed that young patients with AVB of unknown etiology treated with pacemaker implantation had a significantly higher rate of adverse outcomes compared to controls, with those with persistent AVB at higher risk. These results highlight the need for improved follow-up strategies for young patients with AVB of unknown etiology.
Aims Atrioventricular block (AVB) of unknown aetiology is rare in the young, and outcome in these patients is unknown. We aimed to assess long-term morbidity and mortality in young patients with AVB of unknown aetiology. Methods and results We identified all Danish patients younger than 50 years receiving a first pacemaker due to AVB between January 1996 and December 2015. By reviewing medical records, we included patients with AVB of unknown aetiology. A matched control cohort was established. Follow-up was performed using national registries. The primary outcome was a composite endpoint consisting of death, heart failure hospitalization, ventricular tachyarrhythmia, and cardiac arrest with successful resuscitation. We included 517 patients, and 5170 controls. Median age at first pacemaker implantation was 41.3 years [interquartile range (IQR) 32.7-46.2 years]. After a median follow-up of 9.8 years (IQR 5.7-14.5 years), the primary endpoint had occurred in 14.9% of patients and 3.2% of controls [hazard ratio (HR) 3.8; 95% confidence interval (CI) 2.9-5.1; P < 0.001]. Patients with persistent AVB at time of diagnosis had a higher risk of the primary endpoint (HR 10.6; 95% CI 5.7-20.0; P < 0.001), and risk was highest early in the follow-up period (HR 6.8; 95% CI 4.6-10.0; P < 0.001, during 0-5 years of follow-up). Conclusion Atrioventricular block of unknown aetiology presenting before the age of 50 years and treated with pacemaker implantation was associated with a three- to four-fold higher rate of the composite endpoint of death or hospitalization for heart failure, ventricular tachyarrhythmia, or cardiac arrest with successful resuscitation. Patients with persistent AVB were at higher risk. These findings warrant improved follow-up strategies for young patients with AVB of unknown aetiology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据